|
|
||||||||
Biology of Reproduction, Vol 25, 859-870, Copyright © 1981 by Society for the Study of Reproduction
1 The Ben May Laboratory for Cancer Research,
University of Chicago,
Chicago, Illinois 60637 Uterine peroxidase activity is known to increase dramatically following estrogen treatment and
to be sensitive to modulation by substances which modify the uterine responses to estrogen. However, it is not clear how much of the uterine peroxidase originates within the uterine epithelium
and how much may be due to eosinophils that migrate into the uterus after estrogen treatment. We
have addressed this problem by comparing the distribution of rat uterine peroxidase by biochemical and histochemical methods. Histochemical examination of frozen uterine sections, as well as
biochemical analysis of separated uterine tissue components, demonstrates that the peroxidase is
localized predominantly in cells of the endometrial stroma and myometrium. When the uterine
peroxidase response to estrogens was inhibited to variable degrees by concomitant administration
of progesterone, dexamethasone, the synthetic antiestrogen Cl628, or actinomycin D, parallel
decreases in the uterine eosinophil response were observed. To determine the quantity of uterine
eosinophil peroxidase directly, the peroxidase content of purified eosinophils was measured. With
this specific activity and the estimated number of uterine eosinophils, the total eosinophilic peroxidase of one uterine horn was calculated and found to be quantitatively the same as the total biochemically assayed enzyme of the contralateral horn for various uteri. Solubilized peroxidase of
the uterus and of eosinophils could not be distinguished by sedimentation analysis. These experiments indicate that while the uterine epithelium contains estrogen-inducible peroxidase, virtually
all of the peroxidase activity extracted from estrogen-stimulated uteri originates in the uterine
eosinophils.
Note:
ACKNOWLEDGMENTS
These investigations were supported by grants
RD-84 and BC 279 from the American Cancer Society.
NIH grant HD 15513, and by postdoctoral training
grant CA09183 from the National Cancer Institute for
support of W.J.K. and T.C.A.
This article has been cited by other articles:
![]() |
A Makker, F W Bansode, V M L Srivastava, and M M Singh Antioxidant defense system during endometrial receptivity in the guinea pig: effect of ormeloxifene, a selective estrogen receptor modulator J. Endocrinol., January 1, 2006; 188(1): 121 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Sferruzzi-Perri, S. A. Robertson, and L. A. Dent Interleukin-5 Transgene Expression and Eosinophilia Are Associated with Retarded Mammary Gland Development in Mice Biol Reprod, July 1, 2003; 69(1): 224 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Gouon-Evans and J. W. Pollard Eotaxin Is Required for Eosinophil Homing into the Stroma of the Pubertal and Cycling Uterus Endocrinology, October 1, 2001; 142(10): 4515 - 4521. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Blumenthal, M. Samoszuk, A. P. Taylor, G. Brown, R. Alisauskas, and D. M. Goldenberg Degranulating Eosinophils in Human Endometriosis Am. J. Pathol., May 1, 2000; 156(5): 1581 - 1588. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |